Ma, S., Pradeep, S., Villar-Prados, A., Wen, Y., Bayraktar, E., Mangala, L. S., . . . Sood, A. K. (2019). GnRH-R targeted lytic peptide sensitizes BRCA wild-type ovarian cancer to PARP inhibition. Mol Cancer Ther.
استشهاد بنمط شيكاغوMa, Shaolin, et al. "GnRH-R Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition." Mol Cancer Ther 2019.
MLA استشهادMa, Shaolin, et al. "GnRH-R Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition." Mol Cancer Ther 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.